IDEXX Laboratories, Inc. - Common Stock — Quarterly Cash Flow (NASDAQ:IDXX) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Documents

Quarterly Annual

Total assets 3.21 B3.33 B3.39 B3.35 B3.39 B3.44 B Total liabilities 1.77 B1.87 B1.83 B1.75 B1.83 B1.83 B Total equity 1.45 B1.46 B1.56 B1.61 B1.56 B1.61 B Total liabilities & shareholders' equities 3.21 B3.33 B3.39 B3.35 B3.39 B3.44 B Total debt 449.8 M449.81 M524.82 M449.84 M449.85 M449.86 M Net debt 449.8 M449.81 M166.66 M194.77 M99.33 M252.93 M

News

Idexx (IDXX) Down 7.8% Since Last Earnings Report: Can It Rebound?

Idexx Laboratories (IDXX) is a Top-Ranked Growth Stock: Should You Buy?

Tracking Terry Smith's Fundsmith 13F Portfolio - Q2 2026 Update

Are Wall Street Analysts Predicting IDEXX Laboratories Stock Will Climb or Sink?

Here's Why Idexx Laboratories (IDXX) is a Strong Momentum Stock

Is it a Prudent Move to Retain IDEXX Stock in Your Portfolio Now?

IDXX Raises 2026 EPS Outlook as Diagnostic Growth and Margins Improve

Is IDXX Worth Buying as Growth Strength Meets a Premium Valuation?

IDEXX Laboratories, Inc. (IDXX) Analyst/Investor Day Transcript

IDEXX Labs Executing, But Valuation Continues To Weigh On That Execution (NASDAQ:IDXX)

Zoetis: A Solid Long-Term Buy After Harsh Drawdown (NYSE:ZTS)

S&P 500 Top Stock Gainers Today, 8/14/26 - TipRanks.com